Discover Learning - Social, Emotional and Identity Learning for Very Young Adolescents

NCT04458077 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 333

Last updated 2021-11-04

No results posted yet for this study

Summary

The primary aim of the Discover Learning Project (Discover) is to test an intervention for Very Young Adolescents (VYAs) to promote positive, gender norm transformative, social emotional and identity learning (SEIL). A secondary aim is to better identify effective components of Discover that are scalable requiring the lowest resources to implement

Conditions

  • Behavior, Adaptive
  • Behavior, Child
  • Behavior, Social

Interventions

BEHAVIORAL

Discover Learning (SEIL)

This mobile-phone-based intervention will assess the effectiveness of 10 SEIL sessions conducted at the household level with VYAs. Activities were designed to be done individually, with siblings/peers, and with parents/caregivers. This intervention will look at how household composition and types of practice that can enhance SEIL learning.

Sponsors & Collaborators

  • Health for a Prosperous Nation

    collaborator OTHER
  • Camara Education, Tanzania

    collaborator UNKNOWN
  • Ubongo Learning Limited

    collaborator UNKNOWN
  • Dalberg Global Development Advisors, Tanzania

    collaborator UNKNOWN
  • Save the Children

    collaborator OTHER
  • University of California, Berkeley

    lead OTHER

Principal Investigators

  • Ron Dahl, MD · Institute of Human Development

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
9 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-30
Primary Completion
2020-12-12
Completion
2021-04-30

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04458077 on ClinicalTrials.gov